Stressed mice process noise differently in the brain, altering how they perceive the world
After a week of stress, mice show changes in how their brains process sound, reducing how well they perceive loud noises, ...
PharmiWeb8d
U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics’ Proprietary Radiopharmaceutical Cancer Therapy
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
BioWorld9d
Ariceum’s [225Ac]satoreotide designated US orphan drug for SCLC
Ariceum Therapeutics GmbH’s radiopharmaceutical 225Ac-SSO110 ([225Ac]satoreotide tetraxetran) has been awarded orphan drug designation by the FDA for the treatment of small-cell lung cancer (SCLC).
Crinetics Pharmaceuticals, Inc. (CRNX): One of January’s Biggest Losers
We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at where Crinetics Pharmaceuticals, Inc.
Lantheus acquires Evergreen Theragnostics for $250M upfront payment
Lantheus (LNTH) announced a definitive agreement to acquire Evergreen Theragnostics in an all-cash transaction consisting of an upfront payment ...
ascopubs.org19d
Adjuvant therapy with somatostatin analogs for recurrent gastric neuroendocrine tumors type 1.
Matching adjusted indirect comparison (MAIC) of 177Lu-DOTATATE vs. sunitinib as first-line (1L) treatment for advanced grade 2 (G2) pancreatic neuroendocrine tumors (pNETs). This is an ASCO Meeting ...
Fintel on MSN24d
Jefferies Upgrades Crinetics Pharmaceuticals (CRNX)
Fintel reports that on January 22, 2025, Jefferies upgraded their outlook for Crinetics Pharmaceuticals (NasdaqGS:CRNX) from Hold to Buy. Analyst Price Forecast Suggests 94.74% Upside As of December ...